Genome-wide mRNA analysis of the naïve and MT19c treated xenograft tumors clearly identified MT19c action on FASN expression in MT19c treated ovarian cancer xenograft (p = 0.00000000055) (Fig. 4A) [30]. The gene discussed is FASN; the disease is ovarian cancer.